Gläser, Eva
Kilimann, Ingo
Platen, Moritz
Hoffmann, Wolfgang
Brosseron, Frederic
Buerger, Katharina
Coenjaerts, Marie
Düzel, Emrah
Ewers, Michael
Fliessbach, Klaus
Frommann, Ingo
Gemenetzi, Maria
Glanz, Wenzel
Hellmann-Regen, Julian
Incesoy, Enise I.
Janowitz, Daniel
Jessen, Frank
Peters, Oliver
Priller, Josef
Ramirez, Alfredo
Schneider, Anja
Spottke, Annika
Spruth, Eike Jakob
Teipel, Stefan
Wagner, Michael
Michalowsky, Bernhard
Funding for this research was provided by:
Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE) in der Helmholtz-Gemeinschaft
Article History
Received: 21 February 2025
Accepted: 6 June 2025
First Online: 26 June 2025
Declarations
:
: The study protocol was approved by the ethical committees of the medical faculties of all participating sites: the ethical committees of Berlin (Charité, Universitätsmedizin Berlin), Bonn, Cologne, Göttingen, Magdeburg, Munich (Ludwig-Maximilians-University), Rostock, and Tübingen. The process was led and coordinated by the ethical committee of the medical faculty of the University of Bonn. The trial registration number at the ethical committee in Bonn is 117/13.All participants or their representatives provided written informed consent. DELCODE was conducted in accordance with the Helsinki Declaration of 1975.
: Not applicable.
: The authors declare no competing interests.